Mark Roithmayr, CEO of the Alzheimer's Drug Discovery Foundation, talks about the breakthroughs being made in Alzheimer's treatments and shows how these developments are right on time; and CVS is making big changes to how they price prescriptions. <a href="https://www.alzdiscovery.org/">Alzheimer's Drug Discovery Foundation</a> <a href= "https://www.cnn.com/2023/12/05/investing/cvs-drug-prices/index.html"> CNN News Article: CVS will change the way it prices prescription drugs</a>

Mark Roithmayr, CEO of the Alzheimer's Drug Discovery Foundation, talks about the breakthroughs being made in Alzheimer's treatments and shows how these developments are right on time; and CVS is making big changes to how they price prescriptions. Alzheimer's Drug Discovery Foundation CNN News Article: CVS will change the way it prices prescription drugs

Mark Roithmayr, CEO of the Alzheimer's Drug Discovery Foundation, talks about the breakthroughs being made in Alzheimer's treatments and shows how these developments are right on time; and CVS is making big changes to how they price prescriptions. <a href="https://www.alzdiscovery.org/" rel="noopener noreferrer">Alzheimer's Drug Discovery Foundation</a> <a href="https://www.cnn.com/2023/12/05/investing/cvs-drug-prices/index.html" rel="noopener noreferrer"> CNN News Article: CVS will change the way it prices prescription drugs</a> &nbsp;

Beginning of the End for Alzheimer's

Every Tuesday and Thursday, catch the five-minute Healthcare Policy Pop, a news show covering federal and state health policy updates that impact the chronic and rare disease community.

Share Beginning of the End for Alzheimer's

Sign up to save your podcasts

Beginning of the End for Alzheimer's

Beginning of the End for Alzheimer's